Abstract
Transplacental hMPV-neutralizing antibody transfer was reduced from mothers living with HIV-1. However, a comparison of antibody titers at birth between hMPV hospitalization cases at <6 months and matched controls suggested that reduced maternal antibody might not be the primary cause of the previously reported elevated hMPV risk in HIV-1-exposed infants.
| Original language | English |
|---|---|
| Pages (from-to) | 341-344 |
| Number of pages | 4 |
| Journal | Journal of the Pediatric Infectious Diseases Society |
| Volume | 11 |
| Issue number | 7 |
| DOIs | |
| Publication status | Published - 1 Jul 2022 |
Bibliographical note
Funding Information:This work was partially supported by the South African Research Chairs Initiative of the Department of Science and Innovation/National Research Foundation, the South African Medical Research Council, and the National Research Foundation of South Africa
Publisher Copyright:
© 2022 The Author(s). Published by Oxford University Press on behalf of The Journal of the Pediatric Infectious Diseases Society. All rights reserved.